Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Eklund Foundation now open for applicants within odontology

Eklund Foundation for Odontological Research and Education will distribute approximately EUR 160,000 / MSEK 1.5 to selected research projects in 2017. Applications are accepted through the online application portal at eklundfoundation.org , during the period of 1-31 May 2017. Eklund Foundation invites applicants from all fields of odontology and will particularly prioritize projects that can be related to periodontology, implantology, and cariology. Both experimental and clinical studies are welcome. The successful candidates will be announced in

NeuroVive in-licenses a genetic mitochondrial disease clinical stage project from Yungjin Pharm

Lund, Sweden and Seoul, Korea, 2 May 2017 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market, KRX 003520) today jointly announced that they have entered into a global licensing agreement on Yungjin Pharm’s compound KL1333 for genetic mitochondrial disorders. The in-licensed project is about to enter Phase I clinical development.KL1333 is a drug intended for treatment of orphan genetic mitochondrial disorders. KL1333 acts through modulating the levels of NAD+ and thereby rectifying mitochondrial defects. Yungjin

Change in number of shares and votes in Gränges

The number of shares and votes in Gränges has changed as a result of the exercise of 20,000 warrants within the company’s incentive programs. At the last trading day of the month there was in total 75,175,386 shares and 75,175,386 votes in the company. For further information, please contact: Pernilla Grennfelt, SVP Communications and Investor Relations of Grängespernilla.grennfelt@granges.com, tel: +46 702 90 99 55 The information in this press release is such that Gränges must disclose pursuant to the Financial Instruments Trading Act. The information was submitted for

Ossur Hf : Transactions in relation to share buyback program

Announcement from Össur hf. No. 35/2017Reykjavík, 1 May 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 30 November 2017. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The total consideration for

Insurers Offer Tornado Recovery Tips

AUSTIN, Texas-It was a rough weekend for many as violent storms ripped through northeast Texas. As residents begin the recovery process, the Property Casualty Insurers Association of America (PCI) says the first step is to contact your insurer and start the claims process. “Our thoughts are with those who have been impacted by this recent round of violent weather,” said Joe Woods PCI’s vice president of state government relations. “Homeowners should contact their insurance company or agent through their toll-free phone number, app or website. Insurers plan for catastrophes and are

SDRL - Seadrill Agrees to Sell Three Jack-ups for $225 million

Hamilton, Bermuda, May 1, 2017 - Seadrill Limited ("Seadrill" or "The Company"), announces that it has reached an agreement with Shelf Drilling to sell the West Triton, West Resolute and West Mischief for a total consideration of $225 million subject to customary closing conditions. The West Triton and West Resolute are scheduled to be delivered to Shelf Drilling by the end of May 2017 and the West Mischief during 3Q 2017 after completion of its current drilling contract with NDC in Abu Dhabi.    The total debt outstanding on these three units is $102 million providing excess sale

Vestas - Transactions in connection with share buy-back programme during the period 24 – 28 April 2017

On 8 February 2017, Vestas initiated a share buy-back programme, ref. Company announcement No. 04/2017 . The programme is implemented in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (the "Safe Harbour” rules). The purpose of the programme is to adjust Vestas’ capital structure and to meet the obligations arising from share based incentive programmes to employees of Vestas.  Under the programme Vestas will buy back shares for

Nepa selected to join the Facebook MMM Partner Program

Nepa will now include advertising information from Facebook, Instagram and Audience Network in the Marketing Mix Modeling product. This is available immediately to all Nepa clients around the world.An increasingly large and constantly growing part of a company's media investments is spent in digital media. Digital, consisting of Internet and mobile advertising, will become the largest advertising category already by 2017 according to McKinsey’s Global Media Report 2015 with forecasts through 2019. One of the biggest growth is seen in social media, much thanks to the rapid development

Mölnlycke unveils new Mepilex® innovations at EWMA conference

Mölnlycke is set to launch updated Mepilex® Border Sacrum and Mepilex® Border Heel dressings, followed by new Mepilex® Border Flex and Mepilex® Border Post-Op dressings to be released later this year.Gothenburg, Sweden – 4 May 2017  Mölnlycke, a world-leading medical products and solutions company, today unveiled innovations in its Mepilex® product range at the 27th conference of the European Wound Management Association (EWMA) in Amsterdam, the Netherlands. Mepilex® Border Sacrum and Mepilex® Border Heel dressings – for treatment and prevention of pressure ulcers – now have enhanced

SimCorp A/S – Share buyback program

On 27 February 2017 SimCorp A/S announced a share buyback program in compliance with the provisions of Regulation No. 596/2014 of the European Parliament and of the Council on market abuse (the Market Abuse Regulation - MAR) and delegated legislation under MAR. In connection with the program SimCorp A/S will repurchase shares for an amount of up to EUR 17.5m (approx. DKK 130.4m) in the period from 27 February 2017 to 23 August 2017. The following transactions have been executed under the program:           Date                 Number of shares Average Amount (DKK)

Agromino A/S: Number of Outstanding Shares and Votes

Agromino A/S hereby informs that as of 30 April 2017 the number of outstanding shares and votes in Agromino A/S amounts to 1,742,131,300. The increase of outstanding shares is a result of the issuance of 29 shares following the increase of the share capital carried out on 20 April 2017. Investor enquiries Mr. Simon Boughton, CEO of Agromino A/S Tel: +372 6191 500, e-mail:  mail@agromino.com About Agromino Agromino is an integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Agromino shares are traded on the main

Approval of annual accounts and Board of Director's report for 2016

The Board of Directors of Opera Software ASA has approved the consolidated financial statements, the parent company's financial statements and the Board of Directors' report for 2016.  The following changes have been made compared with the Q4 2016 report released on February 28, 2017: In the Consolidated statement of comprehensive income, Profit (loss) from Discontinued operations has been increased by USD 22.5 million due to a reclassification from foreign currency translation differences from Discontinued operations. There is no change in Total comprehensive income (loss). In the

RayStation selected for major new proton therapy center in China

RayStation will be the treatment planning system for a new proton center in Zhuozhou, Northern China, situated close to Beijing. Around 2,000 patients per year will be treated at Zhuozhou, which will be one of the biggest proton centers in the world. The center will be equipped with IBA’s Proteus®PLUS multi-room system; the setup includes five treatment rooms, four isocentric-gantry treatment rooms and a fixed-beam treatment room. The RayStation order, comprising eight clinical licenses, covers a range of advanced functionality, such as Monte Carlo dose calculation, robust optimization,

Tecnotree’s Annual Report and the Corporate Governance and Remuneration Statements 2016

Tecnotree CorporationStock Exchange Release30 April, 2017 at 3.35 amTecnotree’s Annual Report and the Corporate Governance and Remuneration Statements 2016 are publishedTecnotree’s Annual Report 2016 will be published as online report on the company’s website    http://annualreport2016.tecnotree.com/ on 2 May 2017. The report is available both in Finnish and in English.The Annual Report includes the Financial Statements 2016, including the Board of Directors’ Report.Tecnotree’s Corporate Governance and Remuneration Statements 2016 will be published separately from the Board of

Tecnotree Auditor’s Report

Tecnotree CorporationStock Exchange ReleaseApril 29, 2017 at 5.00 pmThis is the Auditor’s report for the year ended 31 December 2016 to the Annual General Meeting of Tecnotree Corporation:This document is an English translation of the Finnish auditor’s report. Only the Finnish version of the report is legally binding.Auditor’s ReportTo the Annual General Meeting of Tecnotree CorporationReport on the Audit of the Financial StatementOpinionWe have audited the financial statements of Tecnotree Corporation (business identity code 1651577-0) for the year ended 31 December 2016.

First Quarter 2017: Improving Margins with an acquisition at completion stage

Cognosec AB (publ) (“Cognosec” or “The Company”), Nasdaq: COGS a leading supplier of solutions within Cyber Security with operations in Europe, Africa and the Middle East, today announces its first quarter interim report for 2017.Total revenues of 3.76m EUR (Q1 2016: 3.98m EUR) reflected positive traction in key markets, but delays of key contracts in others, where ongoing tenders have not been closed. Increased group costs were incurred to harmonise operations and drive future margin. These effects stretched the Group’s cash position, pending debtor collections and unwinding of deposits.

Sawmills in Quebec and Ontario are running at record high levels, resulting in difficulty finding outlets for generated residuals

Record high production at sawmills in Ontario and Quebec in 2016 has generated large volumes of residues in the two provinces, reports the North American Wood Fiber Review. In the past that would have been good news for the local pulp industry, but with a declining pulp and paper sector, many sawmills are finding it difficult to sell their byproduct locally.Seattle, USA. Sawmills in Eastern Canada have been running at record high levels in 2016, with production reaching levels almost ten percent higher than in 2015 and almost 40 percent higher than five years ago. This has been very good

Election of home member state for bonds

SCA Hygiene AB has elected Sweden as home member state due to its issuance and listing of bonds, March 15, 2017, at the Luxemburg Stock Exchange pursuant to Article 2.1 (i) in the EU Transparency Directive (2004/109/EC). NB. This information is such that SCA is obligated to make public pursuant to the Swedish Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 20:00 CET on April 28, 2017.   Karl Stoltz, Media Relations Manager, +46 8 788 51 55

Notice of stabilisation measures

Skandinaviska Enskilda Banken AB (publ) (”SEB” or ”Global Coordinator”) notifies that stabilisation measures have been effected in Actic Group AB’s (publ) (“Actic” or the “Company”) shares on Nasdaq Stockholm. Not for disclosure, distribution or publication, directly or indirectly, in or into the US, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or Singapore.According to the announcement in connection to the offer to acquire shares in Actic and the listing of the Company’s shares on Nasdaq Stockholm (the “Offering”) the Global Coordinator may effect transactions on

Annual general meeting of HEXPOL AB

At today’s Annual General Meeting of HEXPOL AB (publ), the following was resolved.  Board of Directors, auditor and fees   The number of directors will be seven. The meeting re-elected Georg Brunstam, Alf Göransson, Jan-Anders Månson, Malin Persson, Kerstin Lindell and Märta Schörling Andreen. The meeting also elected Gun Nilsson as new ordinary Board Member. Georg Brunstam was elected Chairman of the Board. The fees to the Board of Directors shall amount to a total of SEK 3,425,000 (including fees for committee work). Re-election of the accounting firm Ernst & Young AB, for a

Change in number of shares and votes in Oncopeptides AB (publ)

During April, the number of shares and votes in Oncopeptides AB (publ) (”Oncopeptides” or the ”Company”) has increased by 977 906 shares and votes due to the new issue of shares that was made in connection with the exercise of the over-allotment option, subsequent to the listing of the Company’s shares on Nasdaq Stockholm. As of April 28, 2017, the number of shares and votes in Oncopeptides amounts to 39,806,021.   About OncopeptidesOncopeptides is a research and development stage pharmaceutical company developing drugs for the treatment of cancer. Since the founding of the company

Number of outstanding shares in Elekta AB

STOCKHOLM, April 28, 2017 – The total number of shares in Elekta as of April 28, 2017, amounts to 383,568,409 divided between 14,980,769 A-shares and 368,587,640 B-shares.The increase of 730,769 new A-shares and 8,205 new B-shares is attributable to the conversion of shares within the framework of the 2012/17 convertible bond. One A-share entitles the holder to ten votes and one B-share to one vote. # # # For further information, please contact:Tobias Bülow, Director Financial Communication, Elekta ABTel: +46 722 215 017, e-mail: tobias.bulow@elekta.comTime zone: CET: Central

There are no items matching the current filter
There are no more items matching the current filter
Back to top